1009P Current strategies of cell and gene therapy for solid tumors: Preliminary results of the joint international ESMO and EBMT Cell Therapy and Immunobiology Working Party questionnaire-based survey

P Comoli,G Pentheroudakis,P Pedrazzoli,A Ruggeri,U Koehl,F Lordick,K Mauff,J.D Hoogenboom,A Urbano-Ispizua,S Peters,C Chabannon,J.B.A.G Haanen

doi:10.1016/j.annonc.2021.08.1393

1009P Current strategies of cell and gene therapy for solid tumors: Preliminary results of the joint international ESMO and EBMT Cell Therapy and Immunobiology Working Party questionnaire-based survey

P Comoli, G Pentheroudakis + Show 10 more

Open Access

https://doi.org/10.1016/j.annonc.2021.08.1393

Copy DOI

Journal: Annals of Oncology	Publication Date: Sep 1, 2021
License type: publisher-specific-oa

Affiliation: Hannover Medical School, University Hospital of Lausanne, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

#Gene Therapy For Solid Tumors #Advanced Therapy Medicinal Products + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Among novel strategies for treatment of solid tumors (ST), cell and/or gene therapy (CT/GT) products are increasingly under investigation, also based on encouraging results observed in lymphoid cancers with industry-manufactured CAR-T-cells. Available information on ongoing studies in ST is limited, due to the variety of programs and infrastructures involved in advanced therapy medicinal products (ATMPs) manufacturing and delivery.

Full Text